← Return to Pancreatic Cancer Recurrence after Whipple

Discussion

Pancreatic Cancer Recurrence after Whipple

Pancreatic Cancer | Last Active: Aug 21 1:48pm | Replies (89)

Comment receiving replies
@asingh90

Hello Bethf, while I know it is tough to find out that the tumor marker tests are going up, it is great news that you are feeling well and the scans are stable so far. In regards to your two options, my understanding is that most clinical trials do require "measurable disease" in order to qualify. Specifically, they need to see at least one centimeter of tumor somewhere in the body that is confirmed either with a biopsy or PET scan showing that it is in fact cancer. You mention in your post that your scans do not show evidence of cancer right now. Please double check the requirements to get on the immunotherapy trial to be sure there is no requirement for measurable disease. If there is such a requirement (which is common), your choices at the moment would only be chemo or waiting until measurable disease appears on the scan. It's difficult to say what is the best option, as you do not want to interrupt the good quality of life you are having now. I would talk to your oncologist and see what he/she recommends. One medium option I can think of is to perhaps try chemotherapy for a month or two and see if your tumor marker numbers go down. If they do, you know it is working and you can continue for some time if you feel your quality of life is still ok while on chemo. If not, you can then attempt to get on the trial. Generally, clinical trials that are not specifically geared to a specific mutation/fusion that your tumor has are used after the standard chemo options are no longer working or tolerable. The great thing right now for you is that you are feeling great and have some time to make a very well researched and planned out treatment decision. This is a huge blessing.

Jump to this post


Replies to "Hello Bethf, while I know it is tough to find out that the tumor marker tests..."

Thanks so much for your response. The requirements of the present study are that you have MRD as indicated by elevated tumor markers and a positive ctDNA test. You have to have been through first-line chemo and surgery. They actually rule you out from participation if you have a scan showing tumor or metastasis. It's a very small hole in the needle to fit through (as are most clinical trial requirements). Also, they are targeting the mutation I have, which is KRAS G-12d. Like I said, it's an almost impossible hole to fit through. The only criteria I did not meet was that I was ctDNA negative, but as of early February Signatera test, I have converted to ctDNA positive, which now qualifies me for the study. I have read the prospectus for the study and the complete Client Consent Form which are very detailed. So, I'm pretty certain that I qualify. Dr. Messersmith is reaching out to the team (he is the head of research here at UC Health Anschutz) and I will know tomorrow whether I qualify. I am glad that I have time to make a reasoned and planful decision. Thanks so much for your input.